Sign in
WithdrawnPhase 2

N2O for Acute Suicidality and Depression in the ED

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 2
Started
27 Feb 2026
Ended
27 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Nitrous oxide gas for inhalation
  • Placebo
Record updated
4 March 2026
Why it stopped
PI has left the university

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Patients 18-65 years of age, acutely suicidal, presenting to the adult emergency department with documented history of non-psychotic major depressive disorder

Who cannot take part

  • Chronic cobalamin and/or folate deficiency treated with folic acid or vitamin B12
  • Lifetime DSM-V (medical history) diagnoses of schizophrenia, schizoaffective disorders, bipolar disorder, obsessive-compulsive disorder, and panic disorders
  • Meets current DSM-V substance use disorder of greater than mild severity (other than nicotine or marijuana)
  • Significant pulmonary disease and/or requiring supplemental oxygen
  • Current psychotic or catatonic symptoms as determined by the hospital care team
  • Unable or unwilling to give consent for study participation (ability to provide consent will be established by treating physician)
  • Administration of other NMDA-receptor antagonist treatment (e.g., ketamine) within two weeks of entry into study
  • Contraindications for N2O (pneumothorax, bowel obstruction, middle ear occlusion, elevated intracranial pressure)
  • Women who are pregnant or breastfeeding
  • Any other factor that in the investigators' judgment may affect patient safety or compliance

Where in United States

  • University of Chicago MedicineChicago, United States

About the trial

What the trial wants to find out

Investigators are conducting this double-blind, randomized control trial (RCT), to compare inhaled N2O+ treatment as usual (TAU) versus inhaled placebo+TAU; demonstrating the feasibility and tolerability of the intervention in an emergency department (ED) setting on an acutely suicidal population.

The 2 groups in the trial

  • Treatment; Nitrous Oxide 50%Existing treatment, for comparison

    A single 45-minute session of inhaled 50% nitrous oxide.

    Treatment: Nitrous oxide gas for inhalation

  • Control; Oxygen-air mixturePlacebo, for comparison

    A single 45-minute session of inhaled Oxygen-air mixture

    Treatment: Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Inhaled Nitrous Oxide for Acute Suicidality and Depression in the Emergency Department
Record updated
4 March 2026